Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gliosarcoma × Hyperbaric Oxygenation × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Radiation Fibrosis Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma 1 Lymphedema 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Fibrosis 1

Interventions

Temozolomide 42 Radiotherapy 33 Bevacizumab 30 Carmustine 12 Irinotecan 10 Erlotinib Hydrochloride 10 sargramostim 7 Thalidomide 7 Chemotherapy, Adjuvant 7 Carboplatin 6 pembrolizumab 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 Topotecan 4 Surgical Procedures, Operative 4 Drug Therapy 4 Celecoxib 4 cediranib 3 aldesleukin 3 Tamoxifen 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy, Conformal 3 O(6)-benzylguanine 3 Gefitinib 3 Filgrastim 3 FANG vaccine 3 Bortezomib 3 Aminolevulinic Acid 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00936052 2010-07-16

HBO

Neurological Surgery, P.C.

Phase 2 Unknown

Glioblastoma, Sarcoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡